Host tissue proteins and extracellular matrix components at the wound surface

Host tissue proteins and extracellular matrix (ECM) components at the wound surface represent a complex, dynamic environment essential for the wound healing process. This target includes structural proteins such as collagen, elastin, and laminin, as well as adhesive glycoproteins like fibronectin and fibrinogen that are exposed or deposited following injury (StatPearls, 2023). These components serve as a scaffold for cell migration, proliferation, and angiogenesis, while also acting as attachment sites for both host cells and invading pathogens via microbial surface components (PubMed, 2021). Pharmacological intervention at this site often involves the use of enzymatic debriding agents to remove damaged proteins, growth factors to stimulate repair, or antimicrobial agents that prevent bacterial colonization of the matrix (NIH, 2022). Understanding the composition and state of these proteins is critical for managing chronic wounds, where dysregulated proteolysis can impede the transition from the inflammatory to the proliferative phase of healing. Therapeutic strategies targeting this environment aim to restore the balance between tissue synthesis and degradation to promote closure. Additionally, the interaction between these host proteins and bacterial adhesins is a key focus for developing anti-infective coatings and dressings.

Other names

Wound bed proteinsExtracellular matrix componentsWound surface matrixHost-derived wound proteins

Drugs interact with these components through enzymatic debridement of necrotic tissue, providing a scaffold for cellular migration, or by forming a protective antimicrobial barrier to prevent pathogen adhesion to host proteins.